Day: July 18, 2025

Company announcement – No. 17 / 2025 Zealand Pharma major shareholder announcement: Van Herk Investments B.V. Copenhagen, Denmark, July 18, 2025 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the discovery and development of innovative peptide-based medicines, today reports receipt on 18 July 2025 of notification pursuant to Section 38 of the Danish Capital Markets Act from the following major shareholder: As of 17 July 2025, Van Herk Investments B.V. (Dutch registration no. 59055057) holds nominally 7,135,191 shares (each share carrying one vote) in Zealand Pharma A/S, corresponding to 10.001% of the total share capital and 10.001% of the total voting rights in Zealand Pharma A/S. Van Herk Investments B.V. is 100% owned by Van Herk Investments THI B.V., which is 100% owned by Van...

– EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) with NF1-PN, a rare genetic disorder with debilitating symptoms – STAMFORD, Conn., July 18, 2025 (GLOBE NEWSWIRE) — SpringWorks Therapeutics, Inc., a healthcare company of Merck, announced today that the European Commission (EC) granted conditional marketing authorization for EZMEKLY® (mirdametinib) for the treatment of symptomatic, inoperable plexiform neurofibromas (PN) in pediatric and adult patients with neurofibromatosis type 1 (NF1) aged 2 years and above. EZMEKLY is the first and only therapy approved in the European Union (EU) for both adults and children with NF1-PN. “Patients with NF1-PN often face physical and mental health challenges and impaired quality of life given the limited treatment options...

– EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) with NF1-PN, a rare genetic disorder with debilitating symptoms – STAMFORD, Conn., July 18, 2025 (GLOBE NEWSWIRE) — SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany, announced today that the European Commission (EC) granted conditional marketing authorization for EZMEKLY® (mirdametinib) for the treatment of symptomatic, inoperable plexiform neurofibromas (PN) in pediatric and adult patients with neurofibromatosis type 1 (NF1) aged 2 years and above. EZMEKLY is the first and only therapy approved in the European Union (EU) for both adults and children with NF1-PN. “Patients with NF1-PN often face physical and mental health challenges and impaired quality of life given...

GRIMSBY, Ontario, July 18, 2025 (GLOBE NEWSWIRE) — Andrew Peller Limited (ADW.A / ADW.B) will issue its financial results for the three months ended June 30, 2025, after close of market on Wednesday, August 6, 2025. Management will host a conference call to discuss the financial results on Thursday, August 7, 2025, at 10:00 a.m. (ET), followed by a question-and-answer period. Q1 FISCAL 2026 CONFERENCE CALL DETAILSDate:  Thursday, August 7, 2025Time:  10:00 a.m. (ET)Dial-in numbers: Local Toronto / International: (437) 900-0527North American Toll Free: (888) 510-2154RapidConnect: https://emportal.ink/4eTJe0KWebcast: A live webcast will be available at ir.andrewpeller.comReplay:  Following the live call, a recording will be available on the Company’s investor relations website at ir.andrewpeller.com   About Andrew...

July 18th, 2025        PHOTOCAT has today applied for a transfer of its trading venue from Nasdaq First North Growth Market to Spotlight Stock Market. The company intends to carry out the transfer to Spotlight Stock Market as soon as possible after Spotlight has approved the application. The main reason for the transfer is the financial benefits that a listing on Spotlight provides. The decision to move Photocat’s shares from Nasdaq First North to Spotlight Stock Market is a strategic one, aimed at optimizing our listing environment to better support our growth trajectory and increase shareholder value. While Nasdaq First North has served us well during our initial growth phase, we believe Spotlight offers a more tailored and advantageous platform for Photocat at this stage of our development. Michael Humle, CEO of Photocat A/S: “This...

HighlightsMineral Processing optimization tests underwayMultiple parallel avenues of testing in progress with the objective of increasing overall magnet rare earths recoveriesLong lead time equipment ordered for a demonstration plantConventional magnetic separation equipment ordered, a critical component of a demonstration plantTest mining set to commenceTest mining at the Cowboy State Mine to provide bulk samples for optimization test work and feedstock for a demonstration plantDENVER, July 18, 2025 (GLOBE NEWSWIRE) — American Rare Earths (ASX: ARR | OTCQX: ARRNF | ADR: AMRRY) (“ARR” or the “Company”), is pleased to provide an update on project activities at Cowboy State Mine (“CSM”), part of the Halleck Creek Rare Earths Project in Wyoming. American Rare Earths, through its subsidiary Wyoming Rare (USA) Inc....

SAULT STE. MARIE, Ontario, July 18, 2025 (GLOBE NEWSWIRE) — Algoma Steel Group Inc. (NASDAQ: ASTL; TSX: ASTL) (“Algoma” or “the Company”), a leading Canadian producer of hot and cold rolled steel sheet and plate products, announced today that it has filed a base shelf prospectus dated July 18, 2025 (the “Base Shelf Prospectus”) with the Ontario Securities Commission, relying on the “well-known seasoned issuer” exemption, and a corresponding shelf registration statement on Form F-10 (the “Registration Statement”) with the United States Securities and Exchange Commission (the “SEC”). These filings will allow the Company, if it chooses, to make offerings of common shares, preferred shares, debt securities, subscription receipts, units and warrants (collectively, the “Securities”) of the Company, or any combination thereof, in all...

MIAMI, July 18, 2025 (GLOBE NEWSWIRE) — Watsco, Inc. (NYSE: WSO) announced today that it will host its second quarter 2025 conference call on Wednesday, July 30, 2025 at 10:00 a.m. (EDT). Prepared remarks regarding the results will be followed by a question-and-answer session with the senior management team. The conference call will be web-cast by CCBN’s StreetEvents and can be found under the link on our website at www.watsco.com. The earnings results will be released before the market opens on July 30, 2025. A replay of the conference call will be available on our website. Investors and analysts are encouraged to pre-register for the conference call by using the link below. Participants who pre-register will be given a unique PIN to gain immediate access to the call. Pre-registration may be completed at any time up to the...

On Friday, 18 July 2025 at 9 am (EET), Coop Pank held an investor webinar, where the Interim Chairman of the Management Board, Heikko Mäe, and the Chief Financial Officer, Paavo Truu, introduced the bank’s unaudited financial results of Second Quarter of 2025. Webinar was held in Estonian language.  Coop Pank would like to thank all participants. Webinar recording is available here: https://youtu.be/VZ40sRcWj-0 Coop Pank’s report for unaudited results of Q1 2025 and the presentation is available here: https://view.news.eu.nasdaq.com/view?id=1379772&lang=en Coop Pank, based on Estonian capital, is one of the five universal banks operating in Estonia. The number of clients using Coop Pank for their daily banking has reached 218,000. Coop Pank aims to put the synergy generated by the interaction of retail business and banking to good...